A novel form of necrosis, TRIAD, occurs in human Huntington's disease

We previously reported transcriptional repression-induced atypical cell death of neuron (TRIAD), a new type of necrosis that is mainly regulated by Hippo pathway signaling and distinct from necroptosis regulated by RIP1/3 pathway. Here, we examined the ultrastructural and biochemical features of neu...

Full description

Saved in:
Bibliographic Details
Published inActa neuropathologica communications Vol. 5; no. 1; p. 19
Main Authors Yamanishi, Emiko, Hasegawa, Kazuko, Fujita, Kyota, Ichinose, Shizuko, Yagishita, Saburo, Murata, Miho, Tagawa, Kazuhiko, Akashi, Takumi, Eishi, Yoshinobu, Okazawa, Hitoshi
Format Journal Article
LanguageEnglish
Published England BioMed Central Ltd 08.03.2017
BioMed Central
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:We previously reported transcriptional repression-induced atypical cell death of neuron (TRIAD), a new type of necrosis that is mainly regulated by Hippo pathway signaling and distinct from necroptosis regulated by RIP1/3 pathway. Here, we examined the ultrastructural and biochemical features of neuronal cell death in the brains of human HD patients in parallel with the similar analyses using mutant Htt-knock-in (Htt-KI) mice. LATS1 kinase, the critical regulator and marker of TRIAD, is actually activated in cortical neurons of postmortem human HD and of Htt-KI mouse brains, while apoptosis promoter kinase Plk1 was inactivated in human HD brains. Expression levels of YAP/YAPdeltaC were decreased in cortical neurons of human HD brains. Ultra-structural analyses revealed extreme enlargement of endoplasmic reticulum (ER), which characterizes TRIAD, in cortical neurons of human HD and those of Htt-KI mice. These biochemical and morphological results support that TRIAD occurs in human and mouse neurons under the HD pathology.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ISSN:2051-5960
2051-5960
DOI:10.1186/s40478-017-0420-1